Conversely, a temporal association with menopausal hormone therapy and incidence of HGSC was found,[REF] and polycystic ovarian syndrome (PCOS) was shown to contribute to a doubling of the risk of ovarian cancer [REF].
Endometriosis can increase risk for other ovarian cancer subtypes, but is not associated with HGSC [REF].